Effectiveness of geriatric assessment and management in older cancer patients: a systematic review and meta-analysis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Frailty and multimorbidity among older cancer patients affect treatment tolerance and efficacy. Comprehensive geriatric assessment and management is recommended to optimize cancer treatment, but its effect on various outcomes remains uncertain. Objective: Our objective was to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) and cost-effectiveness studies comparing comprehensive geriatric assessment (with or without implementation of recommendations) to usual care in older cancer patients. Methods: We searched MEDLINE, EMBASE, CINAHL, and Cochrane trials from inception to January 27, 2023, for RCTs and cost-effectiveness studies. Pooled estimates for outcomes were calculated using random-effects models. Results: A total of 19 full-text articles representing 17 RCTs were included. Average participant age was 72-80 years, and 31%-62% were female. Comprehensive geriatric assessment type, mode of delivery, and evaluated outcomes varied across studies. Meta-analysis revealed no difference in risk of mortality (risk ratio [RR] = 1.08. 95% confidence interval [CI] = 0.91 to 1.29), hospitalization (RR = 0.92, 95% CI = 0.77 to 1.10), early treatment discontinuation (RR = 0.89, 95% CI = 0.67 to 1.19), initial dose reduction (RR = 0.99, 95% CI = 0.99 to 1.26), and subsequent dose reduction (RR = 0.87, 95% CI = 0.70 to 1.09). However, the risk of treatment toxicity was statistically significantly lower in the comprehensive geriatric assessment group (RR = 0.78, 95% CI = 0.70 to 0.86). No cost-effectiveness studies were identified. Conclusion: Compared with usual care, comprehensive geriatric assessment was not associated with a difference in risk of mortality, hospitalization, treatment discontinuation, and dose reduction but was associated with a lower risk of treatment toxicity indicating its potential to optimize cancer treatment in this population. Further research is needed to evaluate cost-effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this population, treatment outcomes are influenced not only by tumor stage, histology, and treatment intensity, but also by host-related factors such as comorbidity, physiologic reserve, immune and metabolic changes, nutritional status, and functional vulnerability (5–8).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Skivington, K., Matthews, L., Simpson, S. A., Craig, P., Baird, J., Blazeby, J. M., Boyd, K. A., Craig, N., French, D. P., McIntosh, E., et al. (2021) · BMJ · doi:10.1136/bmj.n2061 · Cited by 5,808
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.021 · Cited by 5,700
Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., Koffel, J. B., PRISMA-S Group, Blunt, H., Brigham, T., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-020-01542-z · Cited by 3,714
Self-citationRethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., & Koffel, J. (2019) · doi:10.31219/osf.io/sfc38 · Cited by 3,696
Self-citationMohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Research works printed but not linked: 48
- Pilleron, 2019, Global cancer incidence in older adults, 2012 and 2035: a population-based study, Int J Cancer, 144, 49, 10.1002/ijc.31664 · DOI · Paper page
- Berben, 2021, Cancer and aging: two tightly interconnected biological processes, Cancers (Basel), 13, 1400, 10.3390/cancers13061400 · DOI · Paper page
- Ritchie, 2011, Multimorbidity: an issue of growing importance for oncologists, J Oncol Pract, 7, 371, 10.1200/JOP.2011.000460 · DOI · Paper page
- Wildiers, 2014, International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer, J Clin Oncol, 32, 2595, 10.1200/JCO.2013.54.8347 · DOI · Paper page
- Pallis, 2010, EORTC elderly task force position paper: approach to the older cancer patient, Eur J Cancer, 46, 1502, 10.1016/j.ejca.2010.02.022 · DOI · Paper page
- Wieland, 2003, Comprehensive geriatric assessment, Cancer Control, 10, 454, 10.1177/107327480301000603 · DOI · Paper page
- Parker, 2018, What is comprehensive geriatric assessment (CGA)? An umbrella review, Age Ageing, 47, 149, 10.1093/ageing/afx166 · DOI · Paper page
- Ellis, 2017, Comprehensive geriatric assessment for older adults admitted to hospital, Cochrane Database Syst Rev
- Devons, 2002, Comprehensive geriatric assessment: making the most of the aging years, Curr Opin Clin Nutr Metab Care, 5, 19, 10.1097/00075197-200201000-00004 · DOI
- Chen, 2021, Effectiveness of comprehensive geriatric assessment intervention on quality of life, caregiver burden and length of hospital stay: a systematic review and meta-analysis of randomised controlled trials, BMC Geriatr, 21, 377, 10.1186/s12877-021-02319-2 · DOI
- Puts, 2014, An update on a systematic review of the use of geriatric assessment for older adults in oncology, Ann Oncol, 25, 307, 10.1093/annonc/mdt386 · DOI · Paper page
- Puts, 2012, Use of geriatric assessment for older adults in the oncology setting: a systematic review, J Natl Cancer Inst, 104, 1133, 10.1093/jnci/djs285 · DOI · Paper page
- Partridge, 2014, The impact of pre-operative comprehensive geriatric assessment on postoperative outcomes in older patients undergoing scheduled surgery: a systematic review, Anaesthesia, 69, 8, 10.1111/anae.12494 · DOI · Paper page
- Parks, 2012, Comprehensive geriatric assessment for older women with early breast cancer–a systematic review of literature, World J Surg Oncol, 10, 88, 10.1186/1477-7819-10-88 · DOI
- Graf, 2011, Efficiency and applicability of comprehensive geriatric assessment in the emergency department: a systematic review, Aging Clin Exp Res, 23, 244, 10.1007/BF03337751 · DOI
- Garrard, 2020, Comprehensive geriatric assessment in primary care: a systematic review, Aging Clin Exp Res, 32, 197, 10.1007/s40520-019-01183-w · DOI · Paper page
- Eamer, 2018, Comprehensive geriatric assessment for older people admitted to a surgical service, Cochrane Database Syst. Rev
- Hamaker, 2018, The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients–a systematic review, J Geriatr Oncol, 9, 430, 10.1016/j.jgo.2018.03.014 · DOI · Paper page
- Hamaker, 2022, Geriatric assessment in the management of older patients with cancer–a systematic review (update), J Geriatr Oncol, 13, 761, 10.1016/j.jgo.2022.04.008 · DOI · Paper page
- Review Manager (RevMan), 2020, The Cochrane Collaboration.
- Higgins, 2019, Cochrane Handbook for Systematic Reviews of Interventions, 10.1002/9781119536604 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
- 2022, GRADEpro GDT: GRADEpro Guideline Development Tool [Software]
- Mohile, 2021, Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study, Lancet, 398, 1894, 10.1016/S0140-6736(21)01789-X · DOI · Paper page
- Mohile, 2020, Communication with older patients with cancer using geriatric assessment: a cluster-randomized clinical trial from the National Cancer Institute Community Oncology Research Program, JAMA Oncol, 6, 196, 10.1001/jamaoncol.2019.4728 · DOI · Paper page
- Magnuson, 2018, Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study, Support Care Cancer, 26, 605, 10.1007/s00520-017-3874-6 · DOI · Paper page
- Jolly, 2020, A randomized trial of real-time geriatric assessment reporting in nonelectively hospitalized older adults with cancer, Oncologist, 25, 488, 10.1634/theoncologist.2019-0581 · DOI
- Soo, 2022, Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial, Lancet Healthy Longev, 3, e617, 10.1016/S2666-7568(22)00169-6 · DOI · Paper page
- Sattar, 2019, Health status, emergency department visits, and oncologists’ feedback: An analysis of secondary endpoints from a randomized phase II geriatric assessment trial, J Geriatr Oncol, 10, 169, 10.1016/j.jgo.2018.06.014 · DOI
- Puts, 2023, Impact of geriatric assessment and management on quality of life, unplanned hospitalizations, toxicity, and survival for older adults with cancer: the randomized 5C trial, J Clin Oncol, 41, 847, 10.1200/JCO.22.01007 · DOI
- Paillaud, 2022, Effectiveness of geriatric assessment-driven interventions on survival and functional and nutritional status in older patients with head and neck cancer: a randomized controlled trial (EGeSOR), Cancers (Basel), 14, 10.3390/cancers14133290 · DOI
- Ommundsen, 2018, Preoperative geriatric assessment and tailored interventions in frail older patients with colorectal cancer: a randomized controlled trial, Colorectal Dis, 20, 16, 10.1111/codi.13785 · DOI
- Nipp, 2020, Pilot randomized trial of a transdisciplinary geriatric and palliative care intervention for older adults with cancer, J Natl Compr Canc Netw, 18, 591, 10.6004/jnccn.2019.7386 · DOI
- Nipp, 2022, Effects of a perioperative geriatric intervention for older adults with cancer: a randomized clinical trial, J Geriatr Oncol, 13, 410, 10.1016/j.jgo.2022.01.001 · DOI
- Lund, 2021, The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO), Br J Cancer, 124, 1949, 10.1038/s41416-021-01367-0 · DOI · Paper page
- Li, 2021, Geriatric Assessment-Driven Intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial, JAMA Oncol, 7, e214158, 10.1001/jamaoncol.2021.4158 · DOI · Paper page
- Jeppesen, 2018, Impact of comprehensive geriatric assessment on quality of life, overall survival, and unplanned admission in patients with non-small cell lung cancer treated with stereotactic body radiotherapy, J Geriatr Oncol, 9, 575, 10.1016/j.jgo.2018.05.009 · DOI
- Hempenius, 2016, Long term outcomes of a geriatric liaison intervention in frail elderly cancer patients, PLoS One, 11, e0143364, 10.1371/journal.pone.0143364 · DOI
- Hempenius, 2013, Outcomes of a geriatric liaison intervention to prevent the development of postoperative delirium in frail elderly cancer patients: report on a multicentre, randomized, controlled trial, PLoS One, 8, e64834, 10.1371/journal.pone.0064834 · DOI
- DuMontier, 2022, Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies, Haematologica, 107, 1172, 10.3324/haematol.2021.278802 · DOI
- Nadaraja, 2020, The impact of comprehensive geriatric assessment for optimal treatment of older patients with cancer: a randomized parallel-group clinical trial, J Geriatr Oncol, 11, 488, 10.1016/j.jgo.2019.06.019 · DOI
- Puts, 2018, A randomized phase II trial of geriatric assessment and management for older cancer patients, Support Care Cancer, 26, 109, 10.1007/s00520-017-3820-7 · DOI
- Puts, 2021, Never too old to learn new tricks: surveying Canadian healthcare professionals about learning needs in caring for older adults with cancer, J Geriatr Oncol, 12, 262, 10.1016/j.jgo.2020.08.010 · DOI
- Dale, 2021, How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology, J Clin Oncol Oncol Pract, 17, 336, 10.1200/OP.20.00442 · DOI · Paper page
- Gajra, 2022, The use and knowledge of validated geriatric assessment instruments among US community oncologists, J Clin Oncol Oncol Pract, 18, e1081, 10.1200/OP.21.00743 · DOI
- Alibhai, 2022, Economic evaluation of a geriatric oncology clinic, Cancers (Basel), 14, 789, 10.3390/cancers14030789 · DOI
- Craig, 2008, Developing and evaluating complex interventions: The new Medical Research Council guidance, BMJ, 337, a1655, 10.1136/bmj.a1655 · DOI · Paper page
- Puts, 2018, Fighting back against the dilution of the Comprehensive Geriatric Assessment, J Geriatr Oncol, 9, 3, 10.1016/j.jgo.2017.08.009 · DOI
Cited by
Sung, S., Choi, H. J., Jeong, S., Cho, W., Kim, Y. J., Cha, H., Min, C. H., & Kim, M. S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1946212
Metadata
- Authors
- Anwar, M. R., Yeretzian, S. T., Ayala, A. P., Matosyan, E., Breunis, H., Bote, K., Puts, M., Habib, M. H., Li, Q., Sahakyan, Y., Alibhai, S. M. H., & Abrahamyan, L.
- Affiliations
- Institute of Health Policy, Management, and Evaluation, University of Toronto , Toronto, ON, Canada
- Turpanjian College of Health Sciences, American University of Armenia , Yerevan, Armenia
- Gerstein Science Information Centre, University of Toronto , Toronto, ON, Canada
- University of Western Ontario , London, ON, Canada
- Department of Supportive Care, University Health Network , Toronto, ON, Canada
- Lawrence S. Bloomberg Faculty of Nursing, University of Toronto , Toronto, ON, Canada
- Department of Medicine, University Health Network , Toronto, ON, Canada
- Biostatistics Research Unit, University Health Network , Toronto, ON, Canada
- Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network , Toronto, ON, Canada
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-09-20
- Volume
- 115
- Issue
- 12
- Pages
- 1483-1496
- ISSN
- 0027-8874
- 1460-2105
- Cited by
- 47
- References
- 9
- Language
- en
- Funders
- Canadian Cancer Society (#705046)
- Canada Research Chair in the Care of Frail Older Adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of geriatric assessment and management in older cancer patients: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1093/jnci/djad200
- The paper
- Anwar, M. R., Yeretzian, S. T., Ayala, A. P., Matosyan, E., Breunis, H., Bote, K., Puts, M., Habib, M. H., Li, Q., Sahakyan, Y., Alibhai, S. M. H., & Abrahamyan, L. (2023). Effectiveness of geriatric assessment and management in older cancer patients: a systematic review and meta-analysis. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djad200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.